Lv2
140 积分 2025-12-18 加入
The unexpected benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors
13天前
已关闭
Development of TSHR-CAR NK-92 cells for Differentiated Thyroid Cancer
23天前
已完结
Effect of TSH Suppression Therapy on Bone Mineral Density in Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis
23天前
已完结
LBSUN291 Fournier's Gangrene In A Diabetic Male Taking Dapagliflozin
24天前
已完结
Safety of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2is) in Kidney Transplant Recipients
24天前
已关闭
TSH Receptor Monoclonal Antibodies with Agonist, Antagonist, and Inverse Agonist Activities
24天前
已完结
Suppression of Thyrotropin Receptor Constitutive Activity by a Monoclonal Antibody with Inverse Agonist Activity
25天前
已完结
EVALUATING THE EFFECT OF SGLT2 INHIBITORS ON PROTEINURIA AND GLOMERULAR FILTRATION RATE INNON-DIABETIC PATIENTS WITH PROTEINURIA
26天前
已关闭
EUGLYCEMIC DKA WITH SGLT-2 INHIBITORS
26天前
已关闭
Empagliflozin in the management of diabetes mellitus after cardiac transplantation
26天前
已完结
皖公网安备34019202002308
